JD

Jagadhatri Das

Active Director Director DIN 08188133
DIN 08188133 First appointment Jul 2018 Primary industry Machinery and Equipment
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2018
Shareholding value •••• Premium profile

About Jagadhatri Das

Data last updated:

Jagadhatri Das is a Director at Cijen Pharma Machinery Private Limited (since 2018). The company operates in Machinery and Equipment. Cijen Pharma Machinery Private Limited reported revenue of ₹1.23 Cr (FY 2025).

DIN 08188133
Primary Designation Director
Industry Machinery and Equipment
First Appointment 27 Jul 2018
Oldest Company Age 8 yrs
Largest company Cijen Pharma Machinery Private Limited · ₹1.23 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jul 20182018₹1.23 Cr (FY 2025)Active

Board colleagues of Jagadhatri Das

Directorship timeline

Open interactive timeline →
Cijen Pharma Machinery Private Limited
Premium access

Shareholding and investment profile for Jagadhatri Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagadhatri Das

Jagadhatri Das currently holds 1 directorship: Cijen Pharma Machinery Private Limited (Director, since 27 Jul 2018, revenue ₹1.23 Cr (FY 2025)).

Jagadhatri Das was first appointed on 27 Jul 2018 as Director at Cijen Pharma Machinery Private Limited.

The current boards of Jagadhatri Das's companies include Sahmbhunath Bhagabandas Das (Cijen Pharma Machinery Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available